Concepedia

Gary Pastor

GP

13

Publications

980

Citations

13

H-Index

1980

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis (United States)

Gary Pastor is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and neuropharmacology.

Top concepts

Publications per year

1980–2009

13

Publications

13

The N-methyl-d-aspartate antagonists CGS 19755 and CPP reduce ischemic brain damage in gerbils

Carl A. Boast, Susan Gerhardt, Gary Pastor et al. · Brain Research · 1988 · 247 citations

, , +12

CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.

John Lehmann, Jennifer Schneider, Stephen E. McPherson et al. · Journal of Pharmacology and Experimental Therapeutics · 1987 · 238 citations

Fluorescently labeled mesenchymal stem cells (MSCs) maintain multilineage potential and can be detected following implantation into articular cartilage defects

Joseph Quintavalla, Susan Uziel‐Fusi, Jianyun Yin et al. · Biomaterials · 2002 · 128 citations

, , +12

CGS 9896: agonist-antagonist benzodiazepine receptor activity revealed by anxiolytic, anticonvulsant and muscle relaxation assessment in rodents.

Patrick S. Bernard, D A Bennett, Gary Pastor et al. · Journal of Pharmacology and Experimental Therapeutics · 1985 · 73 citations

Novel C5a Receptor Antagonists Regulate Neutrophil Functions In Vitro and In Vivo

Theodore C. Pellas, William C. Boyar, Jan van Oostrum et al. · The Journal of Immunology · 1998 · 59 citations · Full text

, , +22

Rows per page

1–5 of 13